Dr. Quay Discusses Selenium and Its Potential Cancer Risks in Daily Mail

In a recent article published by the Daily Mail, Dr. Quay provided expert insights on a surprising link between selenium, a mineral widely considered a beneficial nutrient, and increased cancer risks.

Known for its essential role in DNA synthesis, thyroid function, and immune support, selenium is frequently touted for its health advantages. However, Dr. Quay highlighted its potential risks when consumed excessively. He explained that while selenium is vital in small, controlled amounts, exceeding the recommended threshold of 400 micrograms per day could lead to selenosis, characterized by symptoms such as garlic breath, brittle nails, and more severe health risks.

“Some studies praise selenium for neutralizing mercury’s toxicity,” said Dr. Quay, “while others caution that it isn’t the cancer shield it’s often portrayed as. The key is dosage. Balance, not abundance, is critical.”

This nuanced perspective underscores the complexity of nutritional supplements and their potential health impacts. As always, moderation and informed guidance from health professionals remain paramount.

Curious to know more?

Read the full article featuring Dr. Quay’s insights on the Daily Mail here:
https://www.dailymail.co.uk/health/article-14623503/common-healthy-superfood-cancer-link-surge-rates.html

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

Watch Dr. Steven Quay’s interview on America at Night as he discusses genetic privacy, public health reform, and the ethics of gain-of-function research. Learn more and preorder Dr. Quay’s new book, The Code as Witness.

Dr. Steven Quay joins Real America’s Voice to explore whether President Biden’s public health changes could reflect the side effects of prostate cancer treatment. Learn how early detection and treatment can affect cognitive and physical health, and why these questions matter for both patients and national leaders.

Dr. Steven Quay joins Fox News to discuss President Biden’s advanced prostate cancer diagnosis, the importance of early detection, and what this means for patients and families. Learn more about the medical facts, treatment options, and why regular screening matters.